How to read ClinicalTrials.gov without a medical degree

The first time you open ClinicalTrials.gov, it feels like reading a legal contract in a second language. Don't let that stop you. You don't need to understand every field — you need to understand about six of them. Here's the map.

The NCT number is the trial's fingerprint

Every registered study has a unique ID that starts with "NCT" followed by eight digits (for example, NCT01234567). Write this down for any trial you flag. It's the single most useful thing to hand your oncologist — it removes all ambiguity about which study you mean.

Recruitment status: can anyone even join?

Near the top of every listing is a status. Most of the time, only one value matters to you:

• Recruiting — actively enrolling participants. This is the one you usually care about.
• Not yet recruiting — approved but hasn't opened yet.
• Active, not recruiting — running, but no longer accepting new participants.
• Completed / Terminated / Withdrawn — closed. Still useful to read for results, but you can't join.

A trial can look exciting and be completely closed. Check status before you get attached.

Phase: what stage of testing is this?

Phase tells you how early and how proven the treatment is — Phase I (safety/dosing), Phase II (does it work?), Phase III (compared to standard care). We cover what each phase means for your family in our guide on questions to ask your oncologist.

Eligibility criteria: the part that rules most trials out

This is the heart of the listing. It's split into two lists:

• Inclusion criteria — what you must have to qualify (a specific diagnosis, stage, biomarker, age range, prior-treatment status).
• Exclusion criteria — what disqualifies you (certain other conditions, recent treatments, organ-function thresholds).

Read these against the private profile you've built. If the inclusion criteria require a mutation your person doesn't have, or exclude a treatment they've already had, the trial likely isn't a fit — and that's fine to note and move on.

Eligibility criteria are written conservatively and full of caveats. Use them to screen out obvious non-matches — never to conclude on your own that someone qualifies. That call belongs to the trial team and your oncologist.

Locations and contacts

Scroll to the locations section to see where the trial runs and whether any site is reachable for your family. Each site usually lists a contact. A trial three time zones away with weekly visits is a very different commitment than one at a regional cancer center.

Interventions and outcome measures

"Interventions" lists the drugs or procedures being tested. "Outcome measures" describe what the study is trying to measure (and how long it runs). You don't need to decode the statistics — just note what's being tested and bring questions about it to your team.

← Back to the blog  ·  Read: how to stay on top of new research →